Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Commentary on tolterodine for men with benign prostatic hyperplasia and lower urinary tract symptoms.

Commentary on tolterodine for men with benign prostatic hyperplasia and lower urinary tract symptoms. J Urol. 2008 May; 179(5 Suppl):S86.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.